Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors

Journal of Surgical Research(2022)10.1016/j.jss.2022.09.025Source: DataRank Database

Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors is a research paper published in Journal of Surgical Research (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.63)OA: closedTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Tyra H. Moyer ORCID,Hillary R. Johnson ORCID,Andrew S Auyeung,Glen Leverson ORCID,Wei Zhang ORCID

Live enrichment

PubMed:36274448 OpenAlex:https://openalex.org/W4306876463

National Institutes of Health

Grant: P30CA014520

National Institutes of Health

Grant: T32CA090217

FWCI

0.63

Citation Percentile

0.7%

Citation Trend

2023

2024

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0022480422006072?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022480422006072?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jss.2022.09.025

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36274448

Fields of Study

Colorectal and Anal CarcinomasCervical Cancer and HPV ResearchCancer-related Molecular Pathways

MeSH Terms

MTOR InhibitorsAnimalsAnal CanalAnus NeoplasmsCarcinoma, Squamous CellIndazolesMaleSulfonamides9,10-Dimethyl-1,2-benzanthracenePhosphatidylinositol 3-KinasesMiceTOR Serine-Threonine Kinases

Keywords

PI3K/AKT/mTOR pathwayDMBAMedicineDysplasiaCancerAnal cancerDiscovery and development of mTOR inhibitorsInternal medicineOncologyCancer researchCarcinogenesisBiologyApoptosisHuman papillomavirusChemopreventionAnal DysplasiaSquamous Cell Carcinoma Of The AnusPi3k/mtor Pathways

Sustainable Development Goals

SDG 0: Good health and well-being

Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors

FAIR Checklist

Authors (8)

Funding (2 grants)

Impact

Open Access

Topics